News
Press Release
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon Technology for Both Antibody Discovery and Cell Line…
View
Article
Time can be the most valuable asset in the drug and therapeutic development processes, especially in situations like the COVID-19…
View
Article
Today’s biotechnology scientists and companies are focused more on working together in the drug and therapy development process to benefit…
View
Press Release
Fargo, N.D. (May 4, 2021) – Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery,…
View
Press Release
Genovac Fargo Fargo, N.D. (April 26, 2021) – A new biotechnology firm has chosen the North Dakota State Research and…
View
Article
The Forum, Fargo, N.D., recently featured Genovac Antibody Discovery’s launch in the North Dakota State University Research & Technology Park,…
View
Webinar
Genovac Research Scientist Patricia Odermatt and Anupam Singhal of Berkeley Lights talk for Digital Week’s Webcast Series on Antibodies, next-generation…
View
Webinar
On November 19 2020 Genovac took part in a webinar hosted by GEN. Panelists from Genovac presented case studies on…
View